| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinical perspective of the U.S. anti-vaccination epidemic: Considering marginal costs and benefits, CDC best practices guidelines, free riders, and herd immunity
|
Anderson, Michael G.
|
|
|
38 |
50 |
p. 7877-7879
|
artikel
|
| 2 |
Adapting Center for Disease Control and Prevention's immunization quality improvement program to improve maternal vaccination uptake in obstetrics
|
Spina, Christine I.
|
|
|
38 |
50 |
p. 7963-7969
|
artikel
|
| 3 |
A novel lamprey antibody sequence to multimerize and increase the immunogenicity of recombinant viral and bacterial vaccine antigens
|
Peubez, Isabelle
|
|
|
38 |
50 |
p. 7905-7915
|
artikel
|
| 4 |
Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine
|
Crooke, Stephen N.
|
|
|
38 |
50 |
p. 7897-7904
|
artikel
|
| 5 |
Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model
|
Chesson, Harrell W.
|
|
|
38 |
50 |
p. 8032-8039
|
artikel
|
| 6 |
Development of Hillchol®, a low-cost inactivated single strain Hikojima oral cholera vaccine
|
Sharma, Tarun
|
|
|
38 |
50 |
p. 7998-8009
|
artikel
|
| 7 |
Does education about local vaccination rates and the importance of herd immunity change US parents’ concern about measles?
|
Griffith, Bridget C.
|
|
|
38 |
50 |
p. 8040-8048
|
artikel
|
| 8 |
Editorial Board/Aims and Scope
|
|
|
|
38 |
50 |
p. IFC
|
artikel
|
| 9 |
Effect of a vaccine information statement (VIS) on immunization status and parental knowledge, attitudes, and beliefs regarding infant immunization in Japan
|
Saitoh, Aya
|
|
|
38 |
50 |
p. 8049-8054
|
artikel
|
| 10 |
Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or older
|
Wolfe, Daniel N.
|
|
|
38 |
50 |
p. 7970-7976
|
artikel
|
| 11 |
Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures
|
Mangion, Mathias
|
|
|
38 |
50 |
p. 7949-7955
|
artikel
|
| 12 |
Expanding global and national influenza vaccine systems to match the COVID-19 pandemic response
|
Ruscio, Bruce A.
|
|
|
38 |
50 |
p. 7880-7882
|
artikel
|
| 13 |
Immune duration of a recombinant PRRSV vaccine expressing E2 of CSFV
|
Gao, Fei
|
|
|
38 |
50 |
p. 7956-7962
|
artikel
|
| 14 |
Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adults
|
Song, Joon Young
|
|
|
38 |
50 |
p. 8016-8023
|
artikel
|
| 15 |
India’s cost-effective COVID-19 vaccine development initiatives
|
Chakraborty, Chiranjib
|
|
|
38 |
50 |
p. 7883-7884
|
artikel
|
| 16 |
Maternal immunization with adjuvanted RSV prefusion F protein effectively protects offspring from RSV challenge and alters innate and T cell immunity
|
Eichinger, Katherine M.
|
|
|
38 |
50 |
p. 7885-7891
|
artikel
|
| 17 |
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
|
Guebre-Xabier, Mimi
|
|
|
38 |
50 |
p. 7892-7896
|
artikel
|
| 18 |
Pneumococcal carriage among children aged 4 – 12 years in Angola 4 years after the introduction of a pneumococcal conjugate vaccine
|
Uddén, Fabian
|
|
|
38 |
50 |
p. 7928-7937
|
artikel
|
| 19 |
Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children
|
Orami, Tilda
|
|
|
38 |
50 |
p. 7977-7988
|
artikel
|
| 20 |
Recombinant H7 hemagglutinin expressed in glycoengineered Pichia pastoris forms nanoparticles that protect mice from challenge with H7N9 influenza virus
|
Liu, Bo
|
|
|
38 |
50 |
p. 7938-7948
|
artikel
|
| 21 |
Rotavirus vaccination and stunting: Secondary Data Analysis from the Peruvian Demographic and Health Survey
|
Loli, Sebastian
|
|
|
38 |
50 |
p. 8010-8015
|
artikel
|
| 22 |
The respiratory syncytial virus fusion protein-specific B cell receptor repertoire reshaped by post-fusion subunit vaccination
|
Schneikart, Gerald
|
|
|
38 |
50 |
p. 7916-7927
|
artikel
|
| 23 |
Vaccination against cocaine using a modifiable dendrimer nanoparticle platform
|
Lowell, Jeffrey A.
|
|
|
38 |
50 |
p. 7989-7997
|
artikel
|
| 24 |
Varicella-zoster-virus vaccination of immunosuppressed children with inflammatory bowel disease or autoimmune hepatitis: A prospective observational study
|
Seitel, Teresa
|
|
|
38 |
50 |
p. 8024-8031
|
artikel
|
Tijdschrift beschrijving